Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. RAPISCAN
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

RAPISCAN

Medicine - Posted on Feb 06 2023
Active substance (DCI)
  • régadénoson
history (3)
  • 1/18/23

    RAPISCAN (régadénoson monohydraté) - Imagerie de perfusion myocardique

    Key points Approval of reimbursement of RAPISCAN (regadenoson) as pharmacological stress agent for myocardial perfusion imag...
    CAV :
    54321
    icône flèche
  • 6/24/20

    RAPISCAN

    New indication. Favourable opinion for reimbursement for diagnostic use as a pharmacological stress agent during the measure...
    CAV :
    54321
    icône flèche
  • 11/20/13

    RAPISCAN (régadénoson), vasodilatateur coronarien sélectif

    Pas d’avantage clinique démontré par rapport à l’adénosine lors de la scintigraphie de perfusion myocardique RAPISCAN est un...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • C01EB21
Manufacturer
GE HEALTHCARE SAS
Presentation

RAPISCAN 400 microgrammes, solution injectable (code CIS : 69075222)
1 flacon de 5 ml (CIP : 34009 584 963 9 4)

All our publications
    Drug therapy Medical imaging Myocardial ischemia

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
0HQapr8mywnuj5h2